Table 3.

The new or ongoing clinical trials to investigate the value of curcumin in cancer clinic^*.

NCT ID	Title
NCT00745134	Curcumin with pre-operative capecitabine and radiation therapy followed by surgery for rectal cancer
NCT00094445	Trial of curcumin in advanced pancreatic cancer
NCT00365209	Curcumin in preventing colon cancer in smokers with aberrant crypt foci
NCT00896103	Curcumin and docetaxel in treating patients with metastatic breast
NCT00192842	Gemcitabine with curcumin for pancreatic cancer
NCT00295035	Phase III trial of gemcitabine, curcumin and celebrex in patients with metastatic colon cancer
NCT00486460	Phase III trial of gemcitabine, curcumin and celebrex in patients with advance or inoperable pancreatic cancer
NCT00003365	Sulindac and plant compounds in preventing colon cancer
NCT00113841	Curcumin (diferuloylmethane derivative) with or without bioperine in patients with multiple myeloma
NCT00118989	Curcumin for the chemoprevention of colorectal cancer
NCT00542711	Bio-availability of a new liquid tumeric extract
NCT00689195	Pilot study of curcumin formulation and ashwagandha extract in advanced osteosarcoma
NCT00475683	Curcumin for prevention of oral mucositis in children chemotherapy
NCT00768118	A capsule containing curcumin, green tea extract, polygonum cuspidatum extract, and soybean extract in healthy participants
NCT00641147	Curcumin for treatment of intestinal adenomas in familial adenomatous polyposis (FAP)

^*Information collected from ClinicalTrials.gov